Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunization.
about
A Blueprint for HIV Vaccine DiscoveryAiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidatesA directed molecular evolution approach to improved immunogenicity of the HIV-1 envelope glycoproteinSemi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro.Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors.Multi-Parameter Exploration of HIV-1 Virus-Like Particles as Neutralizing Antibody Immunogens in Guinea Pigs, Rabbits and MacaquesAntibody responses against xenotropic murine leukemia virus-related virus envelope in a murine model.Stabilization of HIV-1 gp120-CD4 receptor complex through targeted interchain disulfide exchangeEnzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected.Induction of humoral and cellular immune responses against the HIV-1 envelope protein using γ-retroviral virus-like particles.Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructsMucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges.Repeated Vaccination of Cows with HIV Env gp140 during Subsequent Pregnancies Elicits and Sustains an Enduring Strong Env-Binding and Neutralising Antibody Response.A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.HIV-1 virus-like particles produced by stably transfected Drosophila S2 cells: a desirable vaccine component.Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.Neutralizing antibodies to HIV-1 induced by immunization.Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer.Developments in virus-like particle-based vaccines for infectious diseases and cancer.Developments in virus-like particle-based vaccines for HIV.Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology.Dense Array of Spikes on HIV-1 Virion Particles.HIV-1 virus-like particles bearing pure env trimers expose neutralizing epitopes but occlude nonneutralizing epitopes.Flow cytometry based identification of simian immunodeficiency virus Env-specific B lymphocytes.Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV.
P2860
Q26829865-C24441D8-DBC3-4F6C-8675-6CAFFFE3F277Q27489000-12AB1CB1-902A-4BDB-AA07-D6311752613CQ28743092-439C5A7D-D00D-4AFC-851A-D00278643A8FQ30499386-5375BC34-A3FB-4C71-817B-A972999CAE37Q33625151-0DC21217-5E5E-4DCF-9231-7333E9CBE029Q33683203-8452A808-C831-455C-965C-02EE3775467DQ33873719-02A6199E-30F4-411F-BF90-170D2D2729D9Q34055984-3E9DF65A-6D93-4B9B-B1D3-2DED7A20B744Q35076987-9E522E75-F43A-41A1-94C5-131B1C04B56FQ35181739-FE1838D0-7246-4CC1-9812-49F970C6FEDCQ35677724-16EA4B12-88D7-4B1C-99AC-CABC1A3CBEA3Q35883750-229042DB-BA54-404B-B900-EA094470786AQ36051764-E0A42629-234D-441E-8816-67AAB8F46D91Q36149102-382A5210-FB58-4C66-A9D0-21F81CA177E1Q36155445-4CB7A125-4E37-4ABF-BA22-724C8337FB94Q36600380-9661E425-1AC8-4506-95BE-05026109DFCAQ36603515-DE7C90EB-8E0C-4939-8270-8E3A0D1B3091Q36897382-1D2396C9-91BB-495F-A38C-88A3BA5F54DCQ37951525-E2F5E1B9-3F68-4E26-9F25-B0C788357205Q38081965-41E9AD69-E4C3-435C-8542-3007DA435952Q38554795-63FBFFF0-5BD6-4A76-BB58-8BC5BCE0CB77Q38817990-4926948C-DB60-486B-BFDF-CB1B27E1CD76Q39402539-1AE729A1-2AA0-4CE1-81C5-11530704D7C5Q39521335-6D361E76-DB6F-4A00-8EFC-A3AF35D29BFFQ42166543-0AE14BA0-5F0A-44B9-B83D-BD522046CAAC
P2860
Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunization.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Induction of neutralizing anti ...... Env pseudovirion immunization.
@ast
Induction of neutralizing anti ...... Env pseudovirion immunization.
@en
Induction of neutralizing anti ...... Env pseudovirion immunization.
@nl
type
label
Induction of neutralizing anti ...... Env pseudovirion immunization.
@ast
Induction of neutralizing anti ...... Env pseudovirion immunization.
@en
Induction of neutralizing anti ...... Env pseudovirion immunization.
@nl
prefLabel
Induction of neutralizing anti ...... Env pseudovirion immunization.
@ast
Induction of neutralizing anti ...... Env pseudovirion immunization.
@en
Induction of neutralizing anti ...... Env pseudovirion immunization.
@nl
P2093
P2860
P1433
P1476
Induction of neutralizing anti ...... Env pseudovirion immunization.
@en
P2093
Anthony DeVico
Jason Hammonds
Paul Spearman
Timothy Fouts
Xuemin Chen
P2860
P304
14804-14814
P356
10.1128/JVI.79.23.14804-14814.2005
P407
P577
2005-12-01T00:00:00Z